T. Rowe Price Investment Management, Inc. Adma Biologics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,669,191 shares of ADMA stock, worth $28 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,669,191Holding current value
$28 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
407Shares Held
193MCall Options Held
2.13MPut Options Held
1.59M-
Vanguard Group Inc Valley Forge, PA21.4MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$215 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$202 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...